Sirolimus for Kaposi's Sarcoma

Journal of Heart and Lung Transplantation

Volumn 25, Issue 6, 2006, Pages 726-729

  Wasywich, Cara A ^a   Croxson, Margaret C ^a   van Doornum, Gerard J ^b   Coverdale, H Arthur ^a   Ruygrok, Peter N ^c  

^a AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN;

ACUTE KIDNEY FAILURE; ADULT; ANAMNESIS; ARTICLE; CARDIOMYOPATHY; CASE REPORT; CONSTIPATION; DISEASE COURSE; GRAFT REJECTION; HEART TRANSPLANTATION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HIGH RISK PATIENT; HISTOLOGY; HUMAN; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIA; KAPOSI SARCOMA; LYMPHADENOPATHY; MALE; MEDIASTINITIS; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RISK REDUCTION; THORAX RADIOGRAPHY; TUMOR REGRESSION;

ADULT; HEART TRANSPLANTATION; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LUNG NEOPLASMS; MALE; MYOCARDIAL ISCHEMIA; POSTOPERATIVE PERIOD; SARCOMA, KAPOSI; SIROLIMUS;

EID: 33646884814     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2006.01.010     Document Type: Article

References (13)

1. Woodle E.S., Hanaway M., Buell J., et al. Kaposi sarcoma. an analysis of the US and international experiences from the Israel Penn International Transplant Tumor Registry. Transplant Proc 33 (2001) 3660-3661
2. Luppi M., Barozzi P., Santagostino G., et al. Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients. Blood 96 (2000) 3279-3281
3. Barozzi P., Luppi M., Facchetti F., et al. Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nature Med 9 (2003) 554-561
4. Emond J.P., Marcelin A.G., Dorent R., et al. Kaposi's sarcoma associated with previous human herpesvirus 8 infection in heart transplant recipients. J Clin Microbiol 40 (2002) 2217-2219
5. Briz M., Alonso-Pulpon L., Crespo-Leiro M.G., et al. Detection of herpesvirus-like sequences in Kaposi's sarcoma from heart transplant recipients. J Heart Lung Transplant 17 (1998) 288-293
6. Fonseca R., Witzig T.E., Olson L.J., et al. Disseminated Kaposi's sarcoma after heart transplantation. association with Kaposi's sarcoma-associated herpesvirus. J Heart Lung Transplant 17 (1998) 732-736
7. Demirag A., Hizel N., Karakayali H., et al. Kaposi sarcoma-associated herpesvirus/human herpesvirus type 8 and Epstein-Barr virus in immunosuppressed renal transplant recipients. Transplant Proc 30 (1998) 3166-3167
8. Stallone G., Schena A., Infante B., et al. Sirolimus for Kaposi's sarcoma in renal transplant recipients. N Engl J Med 352 (2005) 1317-1323
9. Arican A., Karakayali H., Bilgin N., and Haberal M. Results of treatment in renal transplant patients with Kaposi sarcoma. one-center experience. Transplant Proc 32 (2000) 626-628
10. Kim S., Kang S.H., Moon J., et al. Kaposi sarcoma in renal transplant recipients. Transplant Proc 30 (1998) 3165
11. Keogh A., Richardson M., Ruygrok P., et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years. a randomized clinical trial. Circulation 110 (2004) 2694-2700
12. Eisen H.J., Tuzcu E.M., Dorent R., et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349 (2003) 847-858
13. Hussein M.M., Mooij J.M., and Roujouleh H.M. Regression of post-transplant Kaposi sarcoma after discontinuing cyclosporin and giving mycophenolate mofetil instead. Nephrol Dial Transplant 15 (2000) 1103-1104